Screener
Dyne Therapeutics, Inc. DYN Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Dyne Therapeutics, Inc.’s reported figures.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026. Open the filing →
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
FAQ
- What is Dyne Therapeutics, Inc.'s free cash flow?
- Dyne Therapeutics, Inc. (DYN) reported free cash flow of -$145.14M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s free cash flow changed year-over-year?
- Dyne Therapeutics, Inc.'s free cash flow decreased by 35.8% year-over-year, from -$106.87M to -$145.14M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s free cash flow has grown at a 34.7% compound annual growth rate (CAGR), from -$123.18M to -$405.13M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Dyne Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude